• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Olatec to Conduct a Phase 2 Trial with its NLRP3 Inhibitor, Dapansutrile

    BUSINESSWIRE

    Olatec Announces High-Impact Coverage of Dapansutrile

    BUSINESSWIRE

    Olatec Therapeutics’ Dapansutrile, a Selective NLRP3 Inhibitor

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.